Intensive blood pressure lowering: a practical review

Abstract According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, e...

Full description

Bibliographic Details
Published in:	Clinical Hypertension
Main Authors:	Miguel Camafort, Josep Redón, Wook Bum Pyun, Antonio Coca
Format:	Article
Language:	English
Published:	XMLink 2020-11-01
Subjects:	Intensive blood pressure lowering Ageing Obesity, cardiovascular risk Diabetes mellitus type 2 Ischemic heart disease Chronic kidney disease
Online Access:	http://link.springer.com/article/10.1186/s40885-020-00153-z

Similar Items

Ischaemic heart disease in patients with diabetes mellitus and critical lower limb ischemia
by: Konstantin Vladimirovich Melkozerov, et al.
Published: (2012-09-01)

Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project
by: Guozhe Sun, et al.
Published: (2024-06-01)

Blood pressure control among Veterans with high cardiovascular disease risk
by: Aseel Zghayer, et al.
Published: (2025-03-01)

Potential Impacts of Hydralazine as a Novel Antioxidant on Cardiovascular and Renal Disease—Beyond Vasodilation and Blood Pressure Lowering
by: Ting-Ting Chang, et al.
Published: (2022-11-01)

Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology
by: Elena Zakharova, et al.
Published: (2023-04-01)

The impact of diabetes on the outcomes of lower extremity arterial disease in patients with vascular surgical interventions in Kosovo
by: Dion Haliti, et al.
Published: (2025-09-01)

Blood pressure and its circadian pattern in obese and lean premenopausal women
by: José Silva-Nunes, et al.
Published: (2020-03-01)

Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a meta-analysis of randomized trials
by: Jingjing Hu, et al.
Published: (2023-12-01)

Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial
by: Guozhe Sun, et al.
Published: (2025-03-01)

Serum Magnesium Levels and Cardiovascular Outcomes in Systolic Blood Pressure Intervention Trial ParticipantsPlain-Language Summary
by: Silvia Ferrè, et al.
Published: (2023-06-01)

Does home blood pressure monitoring improve blood pressure‐related outcomes in people living with chronic kidney disease? A systematic review
by: Nathan P. Carey, et al.
Published: (2024-04-01)

Autoantibody against UBE2E3 is a common biomarker for atherosclerotic diseases and digestive tract cancer
by: Takaki Hiwasa, et al.
Published: (2025-05-01)

Blood Pressure Target in Type 2 Diabetes Mellitus
by: Hyun-Jin Kim, et al.
Published: (2022-09-01)

Tight Blood Pressure Control in Chronic Kidney Disease
by: Giorgio Gentile, et al.
Published: (2022-04-01)

Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors
by: Mark Andonovic, et al.
Published: (2023-12-01)

Characteristics of Aphasia in Ischemic Stroke Patients at a National Brain Center in Indonesia
by: Rasya Hapsari Danardhono, et al.
Published: (2023-12-01)

Blood Pressure and Cardiovascular Outcomes in Adults With Diabetes and Chronic Kidney Disease
by: Hyeok‐Hee Lee, et al.
Published: (2025-10-01)

Association of the Intensive Blood Pressure Target and Cardiovascular Outcomes in the Population With Chronic Kidney Disease: A Retrospective Study in Korea
by: Soo‐Young Yoon, et al.
Published: (2024-03-01)

Intensive blood pressure control in isolated systolic hypertension: a post hoc analysis of a cluster randomized trialResearch in context
by: Chang Wang, et al.
Published: (2024-07-01)

Identifying poor cardiorespiratory fitness in overweight and obese children and adolescents by using heart rate variability analysis under resting conditions
by: Pau Redón, et al.
Published: (2020-01-01)

Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
by: I. E. Chazova, et al.
Published: (2022-10-01)

State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023
by: Ryan Chang, BA, et al.
Published: (2025-06-01)

Lower extremity function and cardiovascular disease risk in hemodialysis patients: A multicenter cross‐sectional study
by: Kun Zhang, et al.
Published: (2024-08-01)

Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial
by: Cheol Ho Park, et al.
Published: (2024-08-01)

Impact of Anemia on Cardiovascular Events and All-Cause Death Among Participants Who Received Intense Blood Pressure Treatment: A Secondary Analysis of SPRINT
by: Xiaochuan Liu, et al.
Published: (2024-01-01)

Research Advances of Wnt Signaling Pathway in Ischemic Disease of Lower Extremity
by: Jinhui PENG, et al.
Published: (2016-06-01)

Factores de progresión en pacientes con ERC-3 KDOQI (estudio PROGRESER)
by: Alberto Martínez-Castelao, et al.
Published: (2024-09-01)

Biomedical role of L-carnitine in several organ systems, cellular tissues, and COVID-19
by: I. S. Al-Dhuayan
Published: (2023-01-01)

Relationship between periodontitis and systemic diseases: Leptin, a new biomarker?
by: Hansa Jain, et al.
Published: (2014-01-01)

Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
by: Harold E. Bays, et al.
Published: (2025-02-01)

Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
by: Yifei Cao, et al.
Published: (2025-01-01)

Cardiovascular-Kidney-Metabolic Syndrome: An Update for Clinician
by: Muhammad Yamin, et al.
Published: (2024-06-01)

Impact of Age and Ethnic Variability on Cardiovascular Risk in Chronic Kidney Disease Patients
by: Saif Ullah Shaikh, Afsheen Zehra, Areeb Arif Khan, Habib Saghir, Muhammad Saeed, Muhammad Faisal Fahim
Published: (2025-03-01)

The association of serum leptin levels with metabolic diseases
by: Jen-Pi Tsai
Published: (2017-01-01)

PLASMA LEPTIN LEVELS IN METABOLIC SYNDROME PATIENTS WITH ISCHEMIC HEART DISEASE
by: O. M. Drapkina, et al.
Published: (2016-06-01)

DYSLIPIDEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: O. M. Loboda, et al.
Published: (2014-03-01)

Higher Body Mass Index is associated with increased arterial stiffness prior to target organ damage: a cross-sectional cohort study
by: Nejc Piko, et al.
Published: (2023-09-01)

Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis
by: Xian-Dan Wu, et al.
Published: (2024-12-01)

More intensive versus conservative blood pressure lowering after endovascular therapy in stroke: a meta-analysis of randomised controlled trials
by: Ahmed Naji Mansoor, et al.
Published: (2025-12-01)

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
by: Marion Camoin, et al.
Published: (2022-05-01)